Mercury pollution presents a significant risk to environment and human health, in particular its accumulation in edible fish. The EU-funded Global Mercury Observation and Training network project (ITN GMOS-Train) helped model mercury’s chemical behaviour and fate in land, air and marine environments. The work will support public health initiatives and make more informed dietary choices possible.
Liver disease kills over 130 000 people in Europe every year, driven by obesity, hepatitis and alcohol consumption. The EU-funded FORCE project developed a cutting-edge diagnostic tool to aid early detection of liver disease. The technique, which quantifies the elasticity of soft tissue, can also be used to monitor tumours, improving outcomes for patients undergoing cancer treatment.
Airborne pollutants are a threat to researchers and citizens alike. Using low-cost sensing technologies, the EU-funded VIDIS project hopes to deliver more accurate assessments of particulate matter exposure. Routine monitoring of air quality could offer significant health benefits for EU citizens.
Paediatric oncology researchers in Lithuania often lack opportunities for international research and training. The EU-funded TREL project helped place 32 specialists from Lithuania in Europe’s leading medical institutions. The programme is already having an impact on the treatment of paediatric cancers in Lithuania, and accelerating scientific excellence in this research area.
Synaesthesia, a neurological condition associated with anxiety disorders and autism, is difficult to identify in children. The EU-funded SYN-TOOLKIT project developed a new method to gather evidence of this perceptual phenomenon. The research has led to the development of a diagnostic smartphone app that could help these individuals access support.
The potential for mRNA goes well beyond the COVID-19 vaccine. With the support of the EU-funded MOSaIC project, one research centre in Poland is conducting cutting-edge research in the field, paving the way for new treatments against diseases such as cancer, Alzheimer’s and genetic conditions.
Miniature medical devices have the potential to screen, monitor, diagnose and treat a range of body functions, conditions and diseases. But implanting these devices into the body requires safe, non-toxic materials. The biocompatible materials developed by the EU-funded BioWings project could open the door to a new era of medical innovation for EU citizens and the world.
It was assumed that viruses spread as independent particles called virions. The EU-funded Vis-a-Vis project used social evolution concepts to study viral transmission, showing how viral particles compete and collaborate with one another. An improved understanding of virus-virus interactions paves the way for a new generation of treatments.
Ovarian cancer is often diagnosed too late for treatments to work. The EU-funded EARLYDETECT project developed innovative screening tools capable of detecting the disease early.
This will help patients receive the therapies they need sooner, before the disease spreads, saving the lives of citizens in the EU and beyond.
Many implants can be rejected from the body if the bone doesn’t heal around them properly. The EU-funded BoneImplant project developed new ways to quantify implant status and improve their overall success rate. The research will directly improve the quality of life of EU citizens.
